Nationwide Fund Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-21,718
| Closed | -$435K | – | 1591 |
|
|
2017
Q3 | $435K | Buy |
21,718
+2,713
| +14% | +$54.3K | ﹤0.01% | 2253 |
|
|
2017
Q2 | $348K | Sell |
19,005
-15,100
| -44% | -$276K | ﹤0.01% | 2363 |
|
|
2017
Q1 | $336K | Sell |
34,105
-15,200
| -31% | -$150K | ﹤0.01% | 2364 |
|
|
2016
Q4 | $538K | Buy |
49,305
+14,005
| +40% | +$153K | ﹤0.01% | 2147 |
|
|
2016
Q3 | $495K | Hold |
35,300
| – | – | ﹤0.01% | 2186 |
|
|
2016
Q2 | $248K | Hold |
35,300
| – | – | ﹤0.01% | 2508 |
|
|
2016
Q1 | $227K | Buy |
35,300
+4,464
| +14% | +$28.7K | ﹤0.01% | 2478 |
|
|
2015
Q4 | $999K | Buy |
30,836
+482
| +2% | +$15.6K | ﹤0.01% | 1736 |
|
|
2015
Q3 | $810K | Sell |
30,354
-18,260
| -38% | -$487K | ﹤0.01% | 1834 |
|
|
2015
Q2 | $2.34M | Sell |
48,614
-7,945
| -14% | -$382K | 0.01% | 1348 |
|
|
2015
Q1 | $3.44M | Sell |
56,559
-1,610
| -3% | -$98K | 0.01% | 1167 |
|
|
2014
Q4 | $3.01M | Buy |
58,169
+28,539
| +96% | +$1.48M | 0.01% | 1204 |
|
|
2014
Q3 | $1.3M | Buy |
29,630
+12,609
| +74% | +$555K | 0.01% | 1697 |
|
|
2014
Q2 | $445K | Buy |
17,021
+8,307
| +95% | +$217K | ﹤0.01% | 2326 |
|
|
2014
Q1 | $228K | Buy |
8,714
+1,316
| +18% | +$34.4K | ﹤0.01% | 2436 |
|
|
2013
Q4 | $126K | Buy |
7,398
+4,598
| +164% | +$78.3K | ﹤0.01% | 2885 |
|
|
2013
Q3 | $60K | Buy |
+2,800
| New | +$60K | ﹤0.01% | 3032 |
|